IDH1 and central nervous system cancer: Many reports have shown that IDH1/2 mutation can increase the level of lactate, such as lactate levels in mutIDH1 (R132H) in U87 GBM [245], mutIDH1 (R132H), and mutIDH2 (R172K) in Grade II and III glioma [246].